ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Announcement of Newspaper Publication of loss of Share.17-06-2021
17-06-2021
ZYDUS WELLNESS LTD.-$ - 531335 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Details of Loss of Certificate under Regulation 39(3) of SEBI LODR.15-06-2021
Bharat Biotech begins pediatric trials of COVID-19 vaccine at AIIMS Patna
Currently, Zydus' ZyCoV-D is also under trial for children above the age of 12 in India.03-06-2021
ZYDUS WELLNESS LTD.-$ - 531335 - Intimation Of Related Party Transaction On Consolidated Basis For The Half Year Ended On March 31, 2021.
Intimation of Related Party Transaction on consolidated basis for the half year ended on March 31, 2021.01-06-2021
Covid-19: Zydus seeks DCGI nod to undertake clinical trials for monoclonal antibodies cocktail
ZRC-3308 is a cocktail of 2 anti-SARS-CoV-2 monoclonal antibodies.27-05-2021
COVID-19 vaccination | Should India urgently vaccinate children before third wave? Here is what experts say
Currently, Zydus' ZyCoV-D and Bharat Biotech's Covaxin are the only COVID-19 vaccines under trial for children above the age of 12 in India.22-05-2021
Zydus Animal Health buyout catapults Multiples into the big league
Multiples' deal ticket size in the first fund was only $30 million and in the second around $50 million18-05-2021
Zydus to sell animal healthcare business to Zenex for 2921 crore
Inks agreement to sell businesses in India and some other countries by way of a slump sale12-05-2021
ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of Financial Results.11-05-2021